Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aquinox Pharmaceuticals logo — Discovering and developing small molecule therapeutics to tr...

Aquinox Pharmaceuticals

Discovering and developing small molecule therapeutics to treat cancer and inflammatory diseases since 2004

Founded 2004 Post Ipo Equity Total: $221.39M Biotechnology, Health Care +1

General Information

Company Name Aquinox Pharmaceuticals
Founded Year 2004
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Aquinox Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aquinox Pharmaceuticals

Aquinox Pharmaceuticals Inc. is a Vancouver-based pharmaceutical company that has been dedicated to discovering and developing small molecule therapeutics since its establishment in 2004. With a focus on treating cancer and inflammatory diseases, the company's product portfolio includes AQX-MN100, a medication designed for these purposes. Additionally, Aquinox has a SH2-containing inositol 5'-phosphatase inhibition program aimed at aiding in blood cell recovery. The company received a significant $75.40M Post-IPO Equity investment on 20 September 2016. As the company operates in the Biotechnology, Health Care, and Health and Wellness industries, its innovative approach to treating critical diseases presents a compelling opportunity for investors seeking to support breakthrough advancements in the healthcare sector.

Taxonomy: pharmaceuticals, small molecule therapeutics, cancer treatment, inflammatory disease treatment, AQX-MN100, SH2-containing inositol 5'-phosphatase inhibition program, drug development, bio-pharmaceuticals, cancer therapy, blood cell recovery, Vancouver, Canada

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 20 Sep 2016
Post-IPO Equity •••••• 1 •••• •••• 15 Sep 2015
Series C •••••• 6
Investor Investor Investor Investor
•••• •••• 		03 Apr 2013
Venture Round •••••• - 21 Sep 2011
Venture Round •••••• - 12 Feb 2011

View All 8 Funding Rounds

Aquinox Pharmaceuticals Alternatives & Competitors

Aquinox Pharmaceuticals vs
Tract Bio
Tract Bio United States

Discovering and developing novel therapies to transform the treatment of cancer and inflammatory dis...

2 employees
Health and Wellness, Life Sciences
Aquinox Pharmaceuticals vs
XTuit Pharmaceuticals
XTuit Pharmaceuticals

Pioneering new methods to enhance cancer treatment by focusing on the tumor microenvironment.

Series A
Biotechnology, Health Care
Aquinox Pharmaceuticals vs
Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc.

Developing novel treatments of inflammatory diseases and cancer

Debt Financing
3 employees
Biopharma, Biotechnology
Also compare with: Aquinox Pharmaceuticals vs Radionetics Oncology Radionetics Oncology

FAQ About Aquinox Pharmaceuticals

Discovering and developing small molecule therapeutics to treat cancer and inflammatory diseases since 2004
Aquinox Pharmaceuticals was founded in 2004.
Aquinox Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Aquinox Pharmaceuticals has completed 8 funding rounds, raising a total of $221.39M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Aquinox Pharmaceuticals include Tract Bio, XTuit Pharmaceuticals, Cantex Pharmaceuticals, Inc., Axxia Pharmaceuticals, Radionetics Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aquinox Pharmaceuticals and Tract Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aquinox Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy